Partner with us

Genomic Intelligence for Cancer Discovery

By partnering with leading academic and pharmaceutical researchers, we are creating clinical tools for physicians, identifying patient populations for novel therapeutics, and enabling clinical trials with the goal of improving patient outcomes.

Derive insights from population-level genomics

Better understand the dynamics of pathways and intricate biomarkers such as androgen receptor activity, DNA repair, immune profiling or chemotherapy response activation.

Reveal new biomarkers through comprehensive genomic profiling

We can profile your cohorts using the whole-transcriptome platform in our CLIA-certified, CAP-accredited, NYS-approved laboratory. With this service, you also gain access to the full repertoire of signatures from the GRID.

Enable clinical trials in earlier patient populations

Utilize more than 500 genomic signatures and 85,000 profiles in the GRID database to identify new niche populations for clinical trial design.

Senior man holding up and staring at a red and white pill.

Commercialize your therapies faster

Screen and identify patients efficiently for clinical trial enrollment through our prospective profiling of hundreds of patients per week.

Partner With Us

  • If you or your organization is interested in partnering with us, please provide brief details related to your request.
  • This field is for validation purposes and should be left unchanged.


Fax: 858.766.6575

Customer Support:

Business and partnership inquiries:

Managed care inquiries:

CAP/CLIA Laboratory:

6925 Lusk Boulevard, Suite 200
San Diego, CA 92121

Research and Development:

1152 Mainland Street
Suite 430, Vancouver
BC V6B 4X2